![]() |
市場調査レポート
商品コード
1468319
高度創傷ケア市場レポート:製品、用途、エンドユーザー、地域別、2024~2032年Advanced Wound Care Market Report by Product, Application, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
高度創傷ケア市場レポート:製品、用途、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界の高度創傷ケア市場規模は2023年に106億米ドルに達しました。今後、IMARC Groupは、2032年には170億米ドルに達し、2024~2032年の成長率(CAGR)は5.27%になると予測しています。
先進創傷ケアは、慢性感染症や治癒しない創傷に対して、死んだ組織や炎症を起こしている組織を除去することで専門的な治療を提供する標準的な医療ソリューションです。これには、火傷、潰瘍、術後創傷などの急性と慢性創傷の治療に役立つ薬剤、機器、いくつかの製品が含まれます。銀とアルギン酸塩からなる高度創傷ケア製品は、創傷から余分な水分を取り除き、感染から保護するために広く使用されています。ハイドロゲル、ハイドロコロイド、フィルムドレッシング、フォームドレッシング、アルギン酸塩などがあります。これらは皮膚の保湿を助け、体細胞の成長を促進することで内外の創傷の迅速な治癒を促します。
世界の高齢者人口の増加と褥瘡、糖尿病性足潰瘍、その他の慢性創傷の有病率の上昇は、市場にプラスの影響を与える主要要因の一つです。慢性創傷は複雑で治癒しない感染症であり、治癒段階を順序よく進むことができないです。加えて、糖尿病や肥満の増加、世界の外科手術のニーズの急増が、壊死組織の吸収を助け、手術部位感染症の迅速な治癒に非常に効果的であることから、高度創傷ケア製品の需要を刺激しています。これに伴い、これらの製品の効果や効能が証明されたことに関する個人の意識が高まり、世界中で売上が増加しています。これとは別に、先進的な創傷ケア製品の技術的進歩が市場の成長に寄与しています。例えば、ナノ粒子ベースの創傷治癒・皮膚再生用生理活性分子は、塗布部位上で薬剤放出を維持し、薬剤の治療効果を向上させる。さらに、疼痛管理、整形外科、泌尿器科、修復、臓器移植、再建手術などの診断、予防処置、外科治療を提供する外来手術センター(ASC)の拡大が市場成長を促進しています。
The global advanced wound care market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.27% during 2024-2032.
Advanced wound care is a standard medical solution that provides specialized treatment for chronic infections and non-healing wounds by removing dead and inflamed tissues. It includes medications, equipment, and several products that help treat acute and chronic wounds, such as burns, ulcers, and post-operative wounds. Advanced wound care products comprising silver and alginates are extensively used to remove excess fluids from wounds and protect them from infections. They include hydrogels, hydrocolloids, film and foam dressings, and alginates. They help retain skin moisture and facilitate quick healing of wounds internally and externally by promoting the growth of body cells.
The increasing global geriatric population and the rising prevalence of pressure ulcers, diabetic foot ulcers, and other chronic wounds are among the key factors positively influencing the market. Chronic wounds are complex and non-healing infections that fail to progress through the healing phases in an orderly sequence. In addition, the increasing occurrence of diabetes, obesity, and a significant surge in the need for surgical procedures across the globe are catalyzing the demand for advanced wound care products as they help absorb necrotic tissues, which are highly effective in the rapid healing of surgical site infections. In line with this, the rising awareness among individuals about the proven benefits and effectiveness of these products is increasing their sales worldwide. Apart from this, technological advancements in advanced wound care products are contributing to market growth. For instance, nanoparticle-based wound healing and skin regeneration bioactive molecules over the applied area maintain the drug release and improve the therapeutic effects of drugs. Furthermore, the expansion of Ambulatory Surgical Centers (ASCs) that provide diagnostics, preventive procedures, and surgical care for pain management, orthopedics, urology, restorative, organ transplantation, and reconstructive surgeries, is propelling the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global advanced wound care market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Infection Management
Silver Wound Dressings
Non-silver Dressings
Collagen Dressings
Exudate Management
Hydrocolloids Dressings
Foam Dressings
Alginate Dressings
Hydrogel Dressings
Active Wound Care
Skin Substitutes
Growth Factors
Therapy Devices
Negative Pressure Wound Therapy (NPWT)
Oxygen and Hyperbaric Oxygen Equipment
Electromagnetic Therapy Devices
Others
Chronic Wounds
Pressure Ulcers
Diabetic Foot Ulcers
Venous Leg Ulcers
Arterial Ulcers
Acute Wounds
Burns and Trauma
Surgical Wounds
Hospitals
Community Health Service Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Molnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc.